Market capitalization | JPY1.52t |
Enterprise Value | JPY1.49t |
P/E (TTM) P/E ratio | 28.26 |
EV/FCF (TTM) EV/FCF | 25.29 |
EV/Sales (TTM) EV/Sales | 2.93 |
P/S ratio (TTM) P/S ratio | 2.98 |
P/B ratio (TTM) P/B ratio | 3.27 |
Dividend yield | 1.48% |
Last dividend (FY26) | JPY38.00 |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
17 Analysts have issued a SYSMEX forecast:
17 Analysts have issued a SYSMEX forecast:
Mar '25 |
+/-
%
|
||
Revenue | 508,643 508,643 |
10%
10%
|
|
Gross Profit | 271,978 271,978 |
12%
12%
|
|
EBITDA | 128,708 128,708 |
14%
14%
|
EBIT (Operating Income) EBIT | 89,675 89,675 |
16%
16%
|
Net Profit | 53,669 53,669 |
8%
8%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
Head office | Japan |
CEO | Hisashi Ietsugu |
Founded | 1968 |
Website | www.sysmex.co.jp |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.